Form 4: Agilon Health CMO Plans Future Share Purchase

Agilon Health's Chief Markets Officer, Benjamin Shaker, reported a planned acquisition of 500,000 common shares at a weighted average price of $0.6021, effective March 2, 2026, under a Rule 10b5-1 plan.

Summary

• Benjamin Shaker, Chief Markets Officer of agilon health, inc. (AGL), filed a Form 4 reporting a planned acquisition of common stock.
• The transaction involves the acquisition of 500,000 shares of common stock.
• The shares are to be acquired at a weighted average price of $0.6021 per share, with individual transaction prices ranging from $0.5671 to $0.6137.
• The transaction is scheduled to occur on March 2, 2026.
• This acquisition is being made pursuant to a Rule 10b5-1 pre-arranged trading plan.
• Following this planned transaction, Benjamin Shaker will beneficially own 1,367,674 shares, which includes restricted stock units.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal. A significant planned insider purchase by a Chief Markets Officer, even under a 10b5-1 plan, demonstrates confidence in the company's valuation and future trajectory.

Positives

• A significant planned acquisition of 500,000 shares by a Chief Markets Officer signals strong insider confidence in the company's future prospects.
• The transaction is executed under a Rule 10b5-1 plan, indicating a pre-meditated decision to acquire shares, often based on a long-term positive outlook.

Future Outlook

The filing does not provide a general future outlook for the company, but it indicates a specific future transaction by a key executive.

Industry Context

StockSavvy.ai notes that insider buying, especially under a Rule 10b5-1 plan, is a common practice for executives to manage their equity holdings compliantly while signaling confidence in their company's long-term value. Such planned purchases are often viewed positively by the market as they reflect an insider's belief in the company's future performance.

Corporate Governance

Stakeholder Impact

• Shareholders may interpret this planned insider purchase as a positive indicator of management's belief in the company's value, potentially boosting investor confidence.
• Employees may see this as a sign of stability and positive future outlook from leadership.

Next Steps

• The planned acquisition of 500,000 shares of common stock by Benjamin Shaker is scheduled for March 2, 2026.

Key Dates

Recommendation

The planned acquisition of a substantial number of shares by a key executive, Benjamin Shaker, signals strong insider confidence in agilon health, inc. This type of insider buying, especially when pre-arranged under a 10b5-1 plan, suggests a deliberate and long-term positive outlook on the company's prospects, making it an attractive signal for investors.

Keywords

agilon health, AGL, insider buying, Form 4, Benjamin Shaker, Chief Markets Officer, stock acquisition, 10b5-1 plan, healthcare services